Tapering, opioid use disorder (OUD), and medication assisted therapy (MAT)
Opioid learning network series - session 5
About
Over 100,000 opioid overdose deaths were reported in the U.S. last year and in Minnesota, opioid overdose deaths were up over 26.1% from 2020, with over 1,300 deaths in the state. Safe prescribing is more important than ever with growing overdose rates, but opioid prescribers are not consistently meeting care standards. In Minnesota, the Department of Human Services found that roughly 300 health care providers’ opioid prescribing rates exceeded quality thresholds. Safe prescribing and knowing how to identify those at risk of an overdose and implementing a safe, effective tapering schedule can reduce the risk of overdose. It is important that providers understand the efficacy of medications to treat opioid use disorder (OUD) to ensure patients are aware and have access to these evidence-based treatments.
During this presentation Hannah Snyder, MD, director/ co-principal investigator and Shiela Klemmetsen, MD, medical director substance use disorder clinic and clinical informaticist, Essentia Health will deep dive into the importance of identifying OUD, how to best taper someone taking a high dose of opioids, and the best treatments for OUD.
Objectives
- Identify indications for starting an opioid taper
- Discuss best practices strategies in managing an opioid taper.
- Recognize signs of substance use disorders and risk factors for overdose
- Discuss the many treatment pathways for those with OUD, including medication assisted treatment (MAT)
Speakers
Hannah Snyder, MD,
Dr. Snyder is the director/ co-principal investigator at CA Bridge a program of the Public Health Institute in Oakland, California. In addition, Dr. Snyder practices primary care and addiction medicine at Zuckerberg San Francisco General Hospital. She is a clinical assistant professor in the Department of Family and Community Medicine at the University of California, San Francisco. Her clinical work includes addiction consultation in clinic and in the hospital, primary care, and hospital medicine. Dr. Snyder completed medical school at the University of Chicago, residency in family and community medicine at the University of California, San Francisco (UCSF), and a fellowship in primary care addiction medicine at UCSF.
Shiela Klemmetsen, MD
Dr. Klemmetsen is medical director substance use disorder clinic and clinical informaticist at Essentia Health, in addition she is studying to become board certified in addiction medicine. She is passionate about providing medication for opioid use disorder (MOUD) and reducing stigma around substance use disorder so it can be treated like other chronic health conditions. She is also a clinical informaticist building order sets, templates, BPAs, and screening. Dr. Klemmetsen graduated from St. Thomas University and attended the University of Minnesota Medical School finishing her residency in Grand Junction, Colorado.
Recommended to attend
Opioid stewardship champions and health care professionals that are interested in learning about improving their organization’s opioid stewardship program, including pharmacists, emergency medicine professionals, mental health and addiction providers, physicians, nurses, and quality improvement teams.
Continuing education
As an ABMS Portfolio Program Sponsor, MHA can help attending physicians and physician assistants receive continuing certification (MOC) credit from their respective specialty board for work related to opioid stewardship, including participation in this webinar.
The program has been designed to meet the Minnesota Board of Nursing continuing education requirements for a total of one contact hour.
Fee
- Complimentary for MHA member hospitals and health systems
- $35 per person for associate members
- $75 per person for nonmembers
Future events in the Opioid Learning Network series
All webinars will be held 1 - 2 p.m., CDT
- Aug 25 - Community engagement and addressing barriers in implementation and adherence
Registration deadline
Please register by noon on the day before the webinar to ensure timely delivery of access instructions.
You will receive an email that contains instructions on how to connect approximately four business days before the web conference. Advance registration is required to ensure delivery of instructional materials.
If you do not receive an email prior to the program with web conference details, please Contact Us to confirm your registration.er